Home
Investors
Incubation Ecosystem
Key Facts
Investments
Fund Management
News & Media
Contact
Home
Investors
Incubation Ecosystem
Key Facts
Investments
Fund Management
News & Media
Contact
Category
press
Norwegian Start-up KinSea Announces First Closing of Seed Financing
25. April 2024
t_kogler
press
CasInvent Pharma Raises € 1.6 million in Pre-Series A Financing to Support the Development of CK1 Inhibitors for Treatment-Resistant Solid and Hematological Tumours
30. Januar 2024
t_kogler
press
Nodus Oncology raises £1.8m ($2.3m) to extend its seed funding
11. Januar 2024
t_kogler
press
Lead Discovery Center GmbH licenses next-generation anticancer drug candidate to HLB Life Science R&D
2. November 2023
t_kogler
press
Norwegian Start-up KinSea to Exploit the Potential of Marine Bioactives for the Treatment of Cancer and other Diseases
8. Februar 2023
t_kogler
press
Nodus Oncology Secures £2.4m ($2.9m) Investment
7. Februar 2023
t_kogler
press
Start-up CalTIC secures up to EUR 3 million in seed financing to develop a new class of drugs targeting TRPC channels
27. September 2022
t_kogler
press
CasInvent Pharma Raises €1.3 Million from KHAN-I and i&i Biotech Fund
13. September 2022
t_kogler
press
Neueste Beiträge
Norwegian Start-up KinSea Announces First Closing of Seed Financing
CasInvent Pharma Raises € 1.6 million in Pre-Series A Financing to Support the Development of CK1 Inhibitors for Treatment-Resistant Solid and Hematological Tumours
Nodus Oncology raises £1.8m ($2.3m) to extend its seed funding
Lead Discovery Center GmbH licenses next-generation anticancer drug candidate to HLB Life Science R&D
Norwegian Start-up KinSea to Exploit the Potential of Marine Bioactives for the Treatment of Cancer and other Diseases
Neueste Kommentare
Archive
April 2024
Januar 2024
November 2023
Februar 2023
November 2022
September 2022
Kategorien
Investments
press
Meta
Anmelden
Feed der Einträge
Kommentare-Feed
WordPress.org
Neueste Kommentare